Merck KGaA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Merck KGaA with three other
pharmaceutical manufacturers in Europe:
of UNITED KINGDOM
sales of £19.06 billion [US$24.28 billion]
of which 100%
Lonza Group AG
(5.92 billion Swiss Francs [US$6.44 billion]
of which 70%
was Pharma&Biotech), and
Novo Nordisk As
based in DENMARK
(122.02 billion Danish Kroner [US$19.20 billion]
of which 84%
was Diabetes and obesity).
Merck KGaA reported sales of 16.15 billion Euro (US$18.91 billion)
December of 2019.
increase of 8.9%
versus 2018, when the company's sales were 14.84 billion Euro.
Sales of Life Science saw an increase
11.0% in 2019, from
6.19 billion Euro to 6.86 billion Euro.